CD28 and graft versus host disease: In line with these findings, Ghosh et al.52 similarly reported that CAR T cells harboring the CD28 co-stimulatory motif demonstrated significantly decreased occurrence of GVHD compared to CAR T cells with the 4-1BB co-stimulatory motif.